Form 4: Novavax Director James F. Young Reports Stock Transactions
SEC Form 4 Filing
Director James F. Young reported transactions involving Novavax Inc. stock, including the acquisition and disposal of shares and derivative securities.
Summary
- On June 12, 2024, James F. Young, a director of Novavax Inc., reported transactions involving the company's stock.
- Young disposed of 6,670 shares of common stock.
- Following the reported transactions, Young beneficially owns 76,760 shares of Novavax common stock.
- Young also reported transactions involving derivative securities, including restricted stock units and stock options.
- Young acquired 15,630 stock options with an exercise price of $15.86, exercisable from June 12, 2025, to June 12, 2034.
- Young acquired 10,420 restricted stock units, vesting from June 12, 2025, to June 12, 2034.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of stock and derivative securities transactions. |
| 06/12/2025 | Start date for exercisability of stock options and vesting of restricted stock units. |
| 06/12/2033 | Expiration date for restricted stock units. |
| 06/12/2034 | Expiration date for stock options. |
| 06/14/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.